Literature DB >> 21801534

Aspirin for prevention of cancer and cardiovascular disease.

Peter W Rose1, Eila K Watson, Lucy S C Jenkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21801534      PMCID： PMC3103689          DOI： 10.3399/bjgp11X578133

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  19 in total

1.  Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study.

Authors:  T Stürmer; R J Glynn; I M Lee; J E Manson; J E Buring; C H Hennekens
Journal:  Ann Intern Med       Date:  1998-05-01       Impact factor: 25.391

2.  Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection.

Authors:  J Rüschoff; S Wallinger; W Dietmaier; T Bocker; G Brockhoff; F Hofstädter; R Fishel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

3.  Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.

Authors:  A Rostom; P Moayyedi; R Hunt
Journal:  Aliment Pharmacol Ther       Date:  2008-11-27       Impact factor: 8.171

Review 4.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

Authors:  Enrico Flossmann; Peter M Rothwell
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 5.  Aspirin: promise and resistance in the new millennium.

Authors:  Carlo Patrono; Bianca Rocca
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-03       Impact factor: 8.311

Review 6.  Aspirin, salicylates, and cancer.

Authors:  Peter C Elwood; Alison M Gallagher; Garry G Duthie; Luis A J Mur; Gareth Morgan
Journal:  Lancet       Date:  2009-03-26       Impact factor: 79.321

Review 7.  Aspirin use and the risk of gastric cancer: a meta-analysis.

Authors:  Ping Yang; Yong Zhou; Bo Chen; Hong-Wei Wan; Gui-Qing Jia; Hai-Long Bai; Xiao-Ting Wu
Journal:  Dig Dis Sci       Date:  2009-08-12       Impact factor: 3.199

8.  Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

Authors:  Andrew T Chan; Shuji Ogino; Charles S Fuchs
Journal:  N Engl J Med       Date:  2007-05-24       Impact factor: 91.245

Review 9.  Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

Authors:  Jack Cuzick; Florian Otto; John A Baron; Powel H Brown; John Burn; Peter Greenwald; Janusz Jankowski; Carlo La Vecchia; Frank Meyskens; Hans Jörg Senn; Michael Thun
Journal:  Lancet Oncol       Date:  2009-05       Impact factor: 41.316

10.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321
View more
  3 in total

1.  Aspirin as adjuvant therapy in childhood cancer?

Authors:  G Morgan
Journal:  Br J Cancer       Date:  2011-11-10       Impact factor: 7.640

2.  Induction of Secretagogue Independent Gastric Acid Secretion via a Novel Aspirin-Activated Pathway.

Authors:  Alice Miriam Kitay; Florentina Sophie Ferstl; Alexander Link; John Peter Geibel
Journal:  Front Physiol       Date:  2019-10-10       Impact factor: 4.566

3.  Aspirin Use among Saudi Adults: The Prevalence and Users' Characteristics.

Authors:  Sultan Alghadeer; Abdulrahman M Alwhaibi; Abdulaziz Alhossan; Salmeen D Babelghaith; Abdullah M Mubarak; Sana Samreen; Nouf N Alameel; Noura N Aljabali; Mohamed N Al-Arifi
Journal:  Saudi Pharm J       Date:  2022-02-11       Impact factor: 4.562
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.